Benefits And Science

A plain-English look at the lab study comparing C15:0 with the fish-oil fatty acid EPA in 12 human cell systems, including funding, patents and limits.

What a 2026 study of the CARDIA and ARIC cohorts found about C15:0, blood pressure and heart disease, and why genetic tests did not show cause.

A plain-English read of the 2024 randomized trial of C15:0 capsules: who took part, the main result, the exploratory findings, funding and limits.

A citable reference of key pentadecanoic acid (C15:0) research numbers: blood levels, cohorts, the supplement trial, lab work, safety and open questions.

What two 2025 studies found about C15 and cancer: a bladder cancer study with cohorts, cells, mice and the gut microbiome, and a 94-cell-line screen pointing to B-cell lymphomas and CCND3. None is a human trial.

The first study to test a C15-rich oil on kidney function found blunted rises in BUN and creatinine in a mouse CKD model, with no survival benefit and no significant histology change. What that does and does not mean.

Fatty15’s marketing frequently references ‘clinical trial’ data, which can imply more than what the underlying study actually establishes. The core

Fatty15 for Skin and Hair: Does C15 Actually Help? Search interest in “Fatty15 for hair” and “Fatty15 for skin” is

Explore how pentadecanoic acid (C15) may relate to red blood cell health and anemia: a look at the evidence, proposed mechanisms, and honest research limits.

Does Fatty15 Lower Cholesterol? Here’s What the Research Says Because C15 (the fatty acid in Fatty15) is a saturated fat,

Exploring early evidence on C15 (pentadecanoic acid) and muscle health: proposed anti-inflammatory mechanisms, exercise recovery, and honest limits of current

Fatty15 is not a weight-loss supplement and is not marketed as one. Here is what C15 research says about metabolic health and body composition.